Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels.
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2012
At a glance
- Drugs Rosuvastatin (Primary) ; Fenofibrate; Omega 3 fatty acids
- Indications Dyslipidaemias
- Focus Pharmacodynamics
- 06 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.